Sinovac Biotech Financial Overview
Sinovac Biotech's market cap is currently $460.27M. The company's EPS TTM is $; its P/E ratio is -4.93; Sinovac Biotech is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.